Table 2 Baseline Clinical and Demographic Characteristics by HBsAg Status
Variable | HBsAg Positive (N = 363) | HBsAg Negative (N = 3929) | p-value |
|---|---|---|---|
Research site, n (%) | Â | Â | 0.004 |
 Urban | 216 (9.6%) | 2028 (90.4%) |  |
 Rural | 147 (7.2%) | 1901 (92.8%) |  |
Gender, n (%) | Â | Â | <.001 |
 Male | 192 (11.9%) | 1419 (88.1%) |  |
 Female | 171 (6.4%) | 2510 (93.6%) |  |
Age group (years), n (%)a | Â | Â | 0.403 |
  < 24 | 22 (8.0%) | 253 (92.0%) |  |
 24–34 | 191 (9.0%) | 1922 (91.0%) |  |
  ≥ 35 | 149 (7.9%) | 1746 (92.1%) |  |
TB status at enrollment, n (%) | Â | Â | 0.564 |
 TB not present | 233 (8.3%) | 2581 (91.7%) |  |
 TB present | 130 (8.8%) | 1348 (91.2%) |  |
Body mass index (kg/m2), n (%)b | Â | Â | 0.007 |
  < 18.5 | 61 (11.6%) | 467 (88.4%) |  |
  ≥ 18.5 | 288 (8.0%) | 3333 (92.0%) |  |
CD4+ count at enrollment (cells/mm3), n (%)c | Â | Â | 0.185 |
  < 50 | 74 (10.6%) | 625 (89.4%) |  |
 50–200 | 173 (8.6%) | 1840 (91.4%) |  |
  ≥ 200 | 93 (8.2%) | 1045 (91.8%) |  |
HIV Viral load (log10 copies/ml), mean (SD) | 5.0 (0.9) | 5.0 (0.9) | 0.179 |